Takahiro Ito

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Randomized Controlled Trial

Top Venues

Journal of personalized medicine

JMIR medical informatics

This page only lists publications with an associated author ORCID identifier.

Publications

Takanobu Hirosawa, Yukinori Harada, Kazuki Tokumasu, Takahiro Ito, Tomoharu Suzuki, Taro Shimizu
Evaluating ChatGPT-4's Diagnostic Accuracy: Impact of Visual Data Integration. JMIR medical informatics 12 (2024)
Takanobu Hirosawa, Yukinori Harada, Kazuki Tokumasu, Takahiro Ito, Tomoharu Suzuki, Taro Shimizu
Evaluating ChatGPT-4's Diagnostic Accuracy: Impact of Visual Data Integration. JMIR medical informatics 12 (2024)
Takanobu Hirosawa, Yukinori Harada, Kazuki Tokumasu, Takahiro Ito, Tomoharu Suzuki, Taro Shimizu
Evaluating ChatGPT-4's Diagnostic Accuracy: Impact of Visual Data Integration. JMIR medical informatics 12 (2024)
Takanobu Hirosawa, Yukinori Harada, Kazuki Tokumasu, Takahiro Ito, Tomoharu Suzuki, Taro Shimizu
Evaluating ChatGPT-4's Diagnostic Accuracy: Impact of Visual Data Integration. JMIR medical informatics 12 (2024)
Takahiro Ito, Takanobu Hirosawa, Yukinori Harada, Shintaro Kakimoto, Taro Shimizu
Evaluation of Internet-Connected Real-Time Remote Auscultation: An Open-Label Randomized Controlled Pilot Trial. Journal of personalized medicine 12 (12) (2022)
Takahiro Ito, Takanobu Hirosawa, Yukinori Harada, Shintaro Kakimoto, Taro Shimizu
Evaluation of Internet-Connected Real-Time Remote Auscultation: An Open-Label Randomized Controlled Pilot Trial. Journal of personalized medicine 12 (12) (2022)
Takahiro Ito, Takanobu Hirosawa, Yukinori Harada, Shintaro Kakimoto, Taro Shimizu
Evaluation of Internet-Connected Real-Time Remote Auscultation: An Open-Label Randomized Controlled Pilot Trial. Journal of personalized medicine 12 (12) (2022)
Takahiro Ito, Takanobu Hirosawa, Yukinori Harada, Shintaro Kakimoto, Taro Shimizu
Evaluation of Internet-Connected Real-Time Remote Auscultation: An Open-Label Randomized Controlled Pilot Trial. Journal of personalized medicine 12 (12) (2022)